Clinical Trial Update: The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial assessing liposomal bupivacaine for postoperative pain and narcotic use after bariatric surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-related Postoperative Pain

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of California, San Francisco | Conditions: Bariatric Surgery Candidate, Pain, Postoperative | Phase 4 | Status: COMPLETED | Results posted: 2020-11-25